Skip to main content

Table 3 Detection rates of csPCa

From: Clinically significant prostate cancer (csPCa) detection with various prostate sampling schemes based on different csPCa definitions

 

SB

TB

ipsi-SB + TB

contra-SB + TB

SB + TB

Detected D1 csPCa cases, n (%)

82 (29.39)

80 (28.67)

104 (37.28)

90 (32.26)

106 (37.99)

P

 < 0.001

 < 0.001

0.066

 < 0.001

-

Detected D2 csPCa cases, n (%)

143 (51.25)

118 (42.29)

146 (52.33)

146 (52.33)

161 (57.71)

P

 < 0.001

 < 0.001

 < 0.001

 < 0.001

-

  1. Statistically significant at P < 0.05. csPCa, clinically significant prostate cancer; SB, systematic biopsy; TB, targeted biopsy; ipsi-SB, ipsilateral SB; contra-SB, contralateral SB; D1, definition 1 (EAU guidelines); D2, definition 2 (Epstein criteria); GS, Gleason score
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us